Loading company
Latest annual · FY2019
Millions- Total revenues
- 489
- Operating income
- 38
- Net income
- 41
- Free cash flow
- 222
Latest quarter · Q2 FY2020
Millions- Total revenues
- 22
- Operating income
- (51)
- Net income
- (50)
- Free cash flow
- (34)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2016 to FY2019
- n/m
AKCEA THERAPEUTICS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Revenue | $488.5 million | $64.9 million | +653.1% | 10-K 2020-03-02 · proof |
| Operating income | $38.1 million | -$230.8 million | 10-K 2020-03-02 · proof | |
| Net income | $40.8 million | -$225.8 million | 10-K 2020-03-02 · proof | |
| Cash from operating activities | $223.8 million | -$202.9 million | 10-K 2020-03-02 · proof | |
| Free cash flow | $222.2 million | -$204 million | 10-K 2020-03-02 · proof | |
| Total assets | $599.3 million | $365.3 million | +64.1% | 10-K 2020-03-02 · proof |
| Total liabilities | $56.2 million | $88.5 million | -36.5% | 10-K 2020-03-02 · proof |
| Cash and cash equivalents | $306.9 million | $86.5 million | +254.9% | 10-K 2020-03-02 · proof |
- What was AKCEA THERAPEUTICS, INC.'s revenue in fiscal 2019?
- AKCEA THERAPEUTICS, INC. reported revenue of $488.5 million for fiscal 2019 (the year ended Dec 31, 2019), against $64.9 million the year before (+653.1%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was AKCEA THERAPEUTICS, INC.'s operating income in fiscal 2019?
- AKCEA THERAPEUTICS, INC. reported operating income of $38.1 million for fiscal 2019 (the year ended Dec 31, 2019), against -$230.8 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was AKCEA THERAPEUTICS, INC.'s net income in fiscal 2019?
- AKCEA THERAPEUTICS, INC. reported net income of $40.8 million for fiscal 2019 (the year ended Dec 31, 2019), against -$225.8 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was AKCEA THERAPEUTICS, INC.'s cash from operating activities in fiscal 2019?
- AKCEA THERAPEUTICS, INC. reported cash from operating activities of $223.8 million for fiscal 2019 (the year ended Dec 31, 2019), against -$202.9 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was AKCEA THERAPEUTICS, INC.'s free cash flow in fiscal 2019?
- AKCEA THERAPEUTICS, INC. reported free cash flow of $222.2 million for fiscal 2019 (the year ended Dec 31, 2019), against -$204 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What are AKCEA THERAPEUTICS, INC.'s total assets?
- As of Dec 31, 2019, AKCEA THERAPEUTICS, INC. reported total assets of $599.3 million, against $365.3 million a year earlier (+64.1%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What are AKCEA THERAPEUTICS, INC.'s total liabilities?
- As of Dec 31, 2019, AKCEA THERAPEUTICS, INC. reported total liabilities of $56.2 million, against $88.5 million a year earlier (-36.5%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What are AKCEA THERAPEUTICS, INC.'s cash and cash equivalents?
- As of Dec 31, 2019, AKCEA THERAPEUTICS, INC. reported cash and cash equivalents of $306.9 million, against $86.5 million a year earlier (+254.9%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1662524&period_type=annual&limit=5"Information only, not investment advice.